- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Cancer Cell Motility (2nd Edition)
Deadline: 2 April 2026
Genetic Alterations and the Tumor Microenvironment
Deadline: 31 March 2026
TGF-β Signaling in the Tumor Microenvironment: Dual Roles in Cancer Progression and Therapy
Deadline: 31 March 2026
Mastering the Immunosuppressive Tumor Microenvironment with Cancer Vaccines
Deadline: 31 March 2026
Targeted Therapy of Cholangiocarcinoma
Deadline: 19 March 2026
The Role of Regucalcin in Cancer
Deadline: 1 March 2026
Drug Resistance Mechanisms and Tumor Microenvironment in Upper Gastrointestinal Cancers
Deadline: 28 February 2026
Mechanistic Insights and Therapeutic Advances in the Prostate Tumor Microenvironment
Deadline: 28 February 2026
Epigenetic Regulation in Cancers
Deadline: 20 February 2026
Transforming Liver Cancer Care: From Molecular Understanding to Novel Therapeutic Strategies
Deadline: 10 February 2026
Advanced Glycation End-Products and Its Receptors in Cancer Progression
Deadline: 31 January 2026
Lymph Node Involvement in Cervical Cancer: From Single Isolated Tumor Cell to Macrometastasis
Deadline: 31 January 2026
of 15

